• Activity INFORMATION

  Overview

  Dravet Syndrome (OS) and Lennox-Gastaut syndrome (LGS) are severe epileptic encephalopathies that ·occur early in life. Characterized by recurrent seizures, both syndromes are difficult to diagnose and treat. While multiple pharmacologic and nonpharmacologic interventions exist, careful selection of therapy is paramount as some medications can exacerbate seizures. As the pharmacotherapy expert, pharmacists can play a major role in ensuring safe and effective therapy for patients by educating providers on appropriate medication choices and doses; and accurately providing education and counseling on medication therapy to patients and family members.
  

  Handouts

  • Slide Document :   19134L01_6pp.pdf Download

  • Slide Document :   19134L01_2pp.pdf Download

  Financial Support By

  Greenwich Biosciences

• Learning OBJECTIVES

  Pharmacist

  Outline the current and emerging pharmacological options for each syndrome and their place in therapy to include agent mechanism of action, pharmacokinetic profile, drug interactions, and risk of adverse effects

  Identify strategies for counseling patients and caregivers on the array of challenges to include daily living, seizure control, and range of resources available to improve quality of life

  Describe the pathophysiology of Dravet and Lennox-Gastaut Syndrome

  Nurse

  Describe the pathophysiology of Dravet and Lennox-Gastaut Syndrome

  Outline the current and emerging pharmacological options for each syndrome and their place in therapy to include agent mechanism of action, pharmacokinetic profile, drug interactions, and risk of adverse effects

  Identify strategies for counseling patients and caregivers on the array of challenges to include daily living, seizure control, and range of resources available to improve quality of life

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-663055

  Universal Activity Number

  Pharmacist 0798-0000-19-134-H01-P
  Nurse 0798-0000-19-134-L01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Jacquelyn  Bainbridge, PharmD, FCCP Professor, University of Colorado School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).